echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Roche acquires Danish pharmaceutical company Santaris Pharma for USD 450 million

    Roche acquires Danish pharmaceutical company Santaris Pharma for USD 450 million

    • Last Update: 2014-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: great wisdom astak news agency announced on Monday that Roche will spend no more than 450 million US dollars to acquire santaris Pharma, a Danish biomedical enterprise

    According to the agreement signed by both parties, Roche will pay 250 million US dollars in advance and 200 million US dollars in the balance after the products reach the expected target

    The acquisition is expected to be completed in August this year

    Santaris Pharma is a Danish biopharmaceutical company founded in 2003

    It mainly uses the unique LND platform and tissue targeting technology to develop antisense gene products

     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.